Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03474341
What this trial is testing

Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+1 more
UMC Utrecht 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06426797
What this trial is testing

Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Peking University People's Hospital 25
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Not applicableLooking for participantsNCT05854823
What this trial is testing

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 23
Large-scale testing (Phase 3)UnknownNCT01064999
What this trial is testing

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Fudan University 240
Testing effectiveness (Phase 2)Study completedNCT00787371
What this trial is testing

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07412171
What this trial is testing

NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

Who this might be right for
Upper Tract Urothelial Carcinoma
Peking University Third Hospital 40
Early research (Phase 1)Study completedNCT00725283
What this trial is testing

Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 34
Post-approval studies (Phase 4)Study completedNCT01227577
What this trial is testing

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Who this might be right for
Chronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 128
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Not applicableUnknownNCT04365803
What this trial is testing

Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial)

Who this might be right for
Breast Cancer
European Institute of Oncology 22
Post-approval studies (Phase 4)Study completedNCT00219310
What this trial is testing

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

Who this might be right for
Recurrent Genital Herpes (RGH)
Novartis
Testing effectiveness (Phase 2)UnknownNCT02511847
What this trial is testing

Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib

Who this might be right for
Triple Negative Breast Cancer
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06831955
What this trial is testing

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Universitaire Ziekenhuizen KU Leuven 356
Post-approval studies (Phase 4)Looking for participantsNCT04650243
What this trial is testing

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

Who this might be right for
Primary Biliary Cholangitis
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06939127
What this trial is testing

Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital 38
Testing effectiveness (Phase 2)Study completedNCT06608537
What this trial is testing

A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer

Who this might be right for
Rectal Cancer
Sun Yat-sen University 52
Post-approval studies (Phase 4)Study completedNCT04512079
What this trial is testing

FREEDOM COVID-19 Anticoagulation Strategy

Who this might be right for
COVID-19SARS-CoV-2
Valentin Fuster 3,460
Testing effectiveness (Phase 2)Study completedNCT01203267
What this trial is testing

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 108
Next Page